Related Experiment Video
Updated: Jun 5, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study
Cem Cerit1, Meltem Vural, S Ükriye Bos Gelmez
1Haydarpas¸a Numune Training and Research Hospital, Istanbul, Turkey. cemcerit@yahoo.com
Psychopharmacology Bulletin
|January 18, 2011
Summary
Antipsychotic medications, particularly clozapine and combined therapies, significantly increase metabolic syndrome risk in schizophrenia and bipolar disorder patients. Lower risk was observed with zuclopenthixol.
Area of Science:
- Psychiatry
- Pharmacology
- Metabolic Disorders
Background:
- Second-generation antipsychotics are associated with high rates of metabolic syndrome (MS) and disturbances.
- Understanding these risks is crucial for managing patients with schizophrenia and bipolar disorder.
Purpose of the Study:
- To investigate the relationship between antipsychotic treatment and MS prevalence.
- To identify specific antipsychotics associated with higher MS rates.
- To compare MS rates in antipsychotic monotherapy versus polytherapy.
- To determine which metabolic parameters are affected by different antipsychotics.
Main Methods:
- A cohort of 242 patients with schizophrenia, schizoaffective disorder, or bipolar disorder was assessed.
- Patients had been on stable antipsychotic and/or mood stabilizer treatment for at least 6 months.
- Metabolic syndrome was evaluated using ATP III and IDF criteria.
Main Results:
- Metabolic syndrome prevalence was highest in the combined antipsychotic (AA) group (48.1% by ATP III) and the clozapine (C) group (74% by IDF).
- The clozapine group exhibited the highest overall metabolic risk.
- Combined antipsychotic therapy also showed a high prevalence of metabolic syndrome.
Conclusions:
- Clozapine and combined antipsychotic treatments pose the highest metabolic risk.
- Olanzapine and risperidone present intermediate metabolic risks.
- Zuclopenthixol was associated with the lowest metabolic risk among the studied antipsychotics.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...